CSIMarket
 


Icagen, Inc.  (ICGND)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

ICGND's Capital Expenditures Growth by Quarter and Year

Icagen,'s Capital Expenditures results by quarter and year




ICGND Capital Expenditures (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - 0.57 0.50 0.81
III Quarter September 0.24 0.36 0.29 0.31
II Quarter June 0.14 0.23 0.25 0.55
I Quarter March 0.84 0.28 0.51 0.13
FY   1.22 1.44 1.55 1.80



ICGND Capital Expenditures third quarter 2019 Y/Y Growth Comment
Icagen, Inc. reported fall in Capital Expenditures in the third quarter 2019 by -33.19% to $ 0.24 millions, from the same quarter in 2018.
The drop in the third quarter 2019 Icagen, Inc.'s Capital Expenditures compares unfavorably to the Company's average Capital Expenditures doubling of 133.75%.

Looking into third quarter 2019 results within Medical Laboratories industry 6 other companies have achieved higher Capital Expenditures growth. While Icagen, Inc.' s Capital Expenditures drop of -33.19% ranks overall at the positon no. 852 in the third quarter 2019.




ICGND Capital Expenditures ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - 14 % -38.27 % 478.57 %
III Quarter September -33.19 % 24.14 % -6.45 % -38 %
II Quarter June -39.13 % -8 % -54.55 % 5400 %
I Quarter March 200 % -45.1 % 292.31 % 160 %
FY   - -7.1 % -13.89 % 157.14 %

Financial Statements
Icagen,'s third quarter 2019 Capital Expenditures $ 0.24 millions ICGND's Income Statement
Icagen,'s third quarter 2018 Capital Expenditures $ 0.36 millions Quarterly ICGND's Income Statement
New: More ICGND's historic Capital Expenditures Growth >>


ICGND Capital Expenditures (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - 58.33 % 72.41 % 161.29 %
III Quarter September 71.81 % 56.52 % 16 % -43.64 %
II Quarter June -83.33 % -17.86 % -50.98 % 323.08 %
I Quarter March 47.37 % -44 % -37.04 % -7.14 %
FY (Year on Year)   - -7.1 % -13.89 % 157.14 %




Capital Expenditures third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #7
Healthcare Sector #132
Overall #852

Capital Expenditures Y/Y Growth Statistics
High Average Low
856.93 % 133.75 % -65.7 %
(June 30. 2016)   (Sep 30 2018)
Capital Expenditures third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #7
Healthcare Sector #132
Overall #852
Capital Expenditures Y/Y Growth Statistics
High Average Low
856.93 % 133.75 % -65.7 %
(June 30. 2016)   (Sep 30 2018)

Capital Expenditures by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Icagen,'s Q/Q Capital Expenditures Growth